Screener
ArriVent BioPharma, Inc. AVBP Q2 2026 earnings
Reported August 12, 2026 · After market close
EPS-$1.05Miss by $0.06
EPS estimate-$0.99
Next report
Nov 16, 2026 (in 2 months)Revenue estimate$800.0K
EPS estimate-$1.07
Versus estimates
Diluted EPS
FAQ
- When did ArriVent BioPharma, Inc. report Q2 2026 earnings?
- ArriVent BioPharma, Inc. (AVBP) reported Q2 2026 earnings on August 12, 2026 after market close.
- What were ArriVent BioPharma, Inc.'s Q2 2026 revenue and EPS?
- ArriVent BioPharma, Inc. reported eps of $-1.05 for Q2 2026.
- Did ArriVent BioPharma, Inc. beat estimates in Q2 2026?
- EPS missed the consensus estimate of $-0.99 by $0.06.
- How did ArriVent BioPharma, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 16.7% from $-0.90.
- Where can I find ArriVent BioPharma, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-094869) and the 10-Q periodic report (0001104659-26-094902) directly on SEC EDGAR. The filing index links above go to sec.gov.
